Oramed Pharmaceuticals Inc. ( ORMP) - Stock Earnings
ORMP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 13.3 million USD | — USD |
| 2025Q3 | 48.4 million USD | — USD |
| 2025Q4 | 21.3 million USD | — USD |
ORMP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.5 million USD | 1.3 million USD |
| 2024 | -19.1 million USD | — USD |
| 2025 | 75.3 million USD | 2.0 million USD |
| 2026 Est. | — | — |
ORMP
Price: $3.77
52 week price:
Dividend Yield: 6.85%
Earnings Per Share: 1.50 USD
P/E Ratio: 2.26
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.6 million
Ebitda: -2.5 millionMarket Capitalization: 149.4 million
Years Paying Dividends: 1